$EYET Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in EYETECH PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in EYETECH PHARMACEUTICALS INC. Get notifications about new insider transactions in EYETECH PHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 21 2004 | EYET | EYETECH PHARMACEUT ... | GUYER DAVID R | Chief Executive Off ... | Sell | S | 41.88 | 40,000 | 1,675,200 | 1,209,500 | 1.2 M to 1.2 M (-3.20 %) |
Dec 21 2004 | EYET | EYETECH PHARMACEUT ... | GUYER DAVID R | Chief Executive Off ... | Option Exercise | A | 43.55 | 250,000 | 10,887,500 | 250,000 | |
Dec 21 2004 | EYET | EYETECH PHARMACEUT ... | GUYER DAVID R | Chief Executive Off ... | Sell | S | 41.88 | 40,000 | 1,675,200 | 1,209,500 | 1.2 M to 1.2 M (-3.20 %) |
Dec 21 2004 | EYET | EYETECH PHARMACEUT ... | PATEL SAMIR CHANDRAKANT | Director | Sell | S | 43.58 | 20,000 | 871,600 | 414,000 | 434 K to 414 K (-4.61 %) |
Dec 21 2004 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Option Exercise | A | 43.55 | 65,000 | 2,830,750 | 65,000 | |
Dec 21 2004 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Option Exercise | A | 43.55 | 40,000 | 1,742,000 | 40,000 | |
Dec 21 2004 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Option Exercise | A | 43.55 | 40,000 | 1,742,000 | 40,000 | |
Nov 30 2004 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Option Exercise | M | 3.50 | 4,000 | 14,000 | 208,429 | |
Nov 30 2004 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Sell | S | 40.30 | 4,000 | 161,200 | 0 | 4 K to 0 (-100.00 %) |
Nov 30 2004 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Buy | M | 3.50 | 4,000 | 14,000 | 4,000 | 0 to 4 K |
Nov 17 2004 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Option Exercise | M | 1.36 | 5,000 | 6,800 | 121,471 | |
Nov 17 2004 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Sell | S | 45.17 | 5,000 | 225,850 | 0 | 5 K to 0 (-100.00 %) |
Nov 17 2004 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Buy | M | 1.36 | 5,000 | 6,800 | 5,000 | 0 to 5 K |
Nov 17 2004 | EYET | EYETECH PHARMACEUT ... | PENHOET EDWARD | Option Exercise | X | 34.34 | 1,041 | 35,748 | 0 | ||
Nov 17 2004 | EYET | EYETECH PHARMACEUT ... | PENHOET EDWARD | Option Exercise | X | 1.44 | 13,750 | 19,800 | 0 | ||
Nov 17 2004 | EYET | EYETECH PHARMACEUT ... | PENHOET EDWARD | Sell | S | 45.41 | 1,041 | 47,275 | 2,604 | 3.6 K to 2.6 K (-28.56 %) | |
Nov 17 2004 | EYET | EYETECH PHARMACEUT ... | PENHOET EDWARD | Sell | S | 45.41 | 13,750 | 624,436 | 3,645 | 17.4 K to 3.6 K (-79.05 %) | |
Nov 17 2004 | EYET | EYETECH PHARMACEUT ... | PENHOET EDWARD | Buy | X | 0.00 | 1,041 | 0 | 17,395 | 16.4 K to 17.4 K (+6.37 %) | |
Nov 17 2004 | EYET | EYETECH PHARMACEUT ... | PENHOET EDWARD | Buy | X | 0.00 | 13,750 | 0 | 17,395 | 3.6 K to 17.4 K (+377.23 %) | |
Nov 17 2004 | EYET | EYETECH PHARMACEUT ... | PENHOET EDWARD | Option Exercise | X | 34.34 | 1,041 | 35,748 | 0 | ||
Nov 17 2004 | EYET | EYETECH PHARMACEUT ... | PENHOET EDWARD | Option Exercise | X | 1.44 | 13,750 | 19,800 | 0 | ||
Nov 17 2004 | EYET | EYETECH PHARMACEUT ... | PENHOET EDWARD | Sell | S | 45.41 | 1,041 | 47,275 | 2,604 | 3.6 K to 2.6 K (-28.56 %) | |
Nov 17 2004 | EYET | EYETECH PHARMACEUT ... | PENHOET EDWARD | Sell | S | 45.41 | 13,750 | 624,436 | 3,645 | 17.4 K to 3.6 K (-79.05 %) | |
Nov 17 2004 | EYET | EYETECH PHARMACEUT ... | PENHOET EDWARD | Buy | X | 0.00 | 1,041 | 0 | 17,395 | 16.4 K to 17.4 K (+6.37 %) | |
Nov 17 2004 | EYET | EYETECH PHARMACEUT ... | PENHOET EDWARD | Buy | X | 0.00 | 13,750 | 0 | 17,395 | 3.6 K to 17.4 K (+377.23 %) | |
Nov 01 2004 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Option Exercise | M | 3.50 | 4,000 | 14,000 | 212,429 | |
Nov 01 2004 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Sell | S | 0.00 | 4,000 | 0 | 0 | 4 K to 0 (-100.00 %) |
Nov 01 2004 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Buy | M | 3.50 | 4,000 | 14,000 | 4,000 | 0 to 4 K |
Oct 29 2004 | EYET | EYETECH PHARMACEUT ... | JP MORGAN PARTNERS BHCA LP | 10% Owner | Sell | S | 41.26 | 1,000,000 | 41,260,000 | 2,240,896 | 3.2 M to 2.2 M (-30.86 %) |
Oct 29 2004 | EYET | EYETECH PHARMACEUT ... | JP MORGAN PARTNERS BHCA LP | 10% Owner | Sell | S | 41.26 | 1,000,000 | 41,260,000 | 2,240,896 | 3.2 M to 2.2 M (-30.86 %) |
Oct 29 2004 | EYET | EYETECH PHARMACEUT ... | WICKER DAMION E MD | Director | Sell | S | 41.26 | 1,000,000 | 41,260,000 | 2,240,896 | 3.2 M to 2.2 M (-30.86 %) |
Oct 29 2004 | EYET | EYETECH PHARMACEUT ... | AKKARAJU SRINIVAS | Director | Sell | S | 41.26 | 1,000,000 | 41,260,000 | 2,240,896 | 3.2 M to 2.2 M (-30.86 %) |
Oct 18 2004 | EYET | EYETECH PHARMACEUT ... | ALTSCHULER DOUGLAS H | Sr VP, Legal, Gener ... | Option Exercise | M | 3.50 | 32,500 | 113,750 | 126,429 | |
Oct 18 2004 | EYET | EYETECH PHARMACEUT ... | ALTSCHULER DOUGLAS H | Sr VP, Legal, Gener ... | Option Exercise | M | 3.50 | 2,500 | 8,750 | 158,929 | |
Oct 18 2004 | EYET | EYETECH PHARMACEUT ... | ALTSCHULER DOUGLAS H | Sr VP, Legal, Gener ... | Sell | S | 43.31 | 32,500 | 1,407,575 | 8,333 | 40.8 K to 8.3 K (-79.59 %) |
Oct 18 2004 | EYET | EYETECH PHARMACEUT ... | ALTSCHULER DOUGLAS H | Sr VP, Legal, Gener ... | Buy | M | 3.50 | 32,500 | 113,750 | 40,833 | 8.3 K to 40.8 K (+390.02 %) |
Oct 18 2004 | EYET | EYETECH PHARMACEUT ... | ALTSCHULER DOUGLAS H | Sr VP, Legal, Gener ... | Sell | S | 42.09 | 2,500 | 105,225 | 8,333 | 10.8 K to 8.3 K (-23.08 %) |
Oct 18 2004 | EYET | EYETECH PHARMACEUT ... | ALTSCHULER DOUGLAS H | Sr VP, Legal, Gener ... | Buy | M | 3.50 | 2,500 | 8,750 | 10,833 | 8.3 K to 10.8 K (+30.00 %) |
Oct 18 2004 | EYET | EYETECH PHARMACEUT ... | ALTSCHULER DOUGLAS H | Sr VP, Legal, Gener ... | Sell | S | 42.09 | 10,000 | 420,900 | 8,333 | 18.3 K to 8.3 K (-54.55 %) |
Oct 15 2004 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Option Exercise | M | 1.36 | 7,500 | 10,200 | 66,029 | |
Oct 15 2004 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Sell | S | 41.25 | 7,500 | 309,375 | 0 | 7.5 K to 0 (-100.00 %) |
Oct 15 2004 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Buy | M | 1.36 | 7,500 | 10,200 | 7,500 | 0 to 7.5 K |
Oct 15 2004 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Option Exercise | M | 1.36 | 7,500 | 10,200 | 66,029 | |
Oct 15 2004 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Sell | S | 41.25 | 7,500 | 309,375 | 0 | 7.5 K to 0 (-100.00 %) |
Oct 15 2004 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Buy | M | 1.36 | 7,500 | 10,200 | 7,500 | 0 to 7.5 K |
Oct 01 2004 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Option Exercise | M | 3.50 | 15,000 | 52,500 | 216,429 | |
Oct 01 2004 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Sell | S | 33.22 | 15,000 | 498,300 | 0 | 15 K to 0 (-100.00 %) |
Oct 01 2004 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Buy | M | 3.50 | 15,000 | 52,500 | 15,000 | 0 to 15 K |
Aug 31 2004 | EYET | EYETECH PHARMACEUT ... | ALTSCHULER DOUGLAS H | Sr VP, Legal, Gener ... | Option Exercise | M | 3.50 | 20,000 | 70,000 | 141,429 | |
Aug 31 2004 | EYET | EYETECH PHARMACEUT ... | ALTSCHULER DOUGLAS H | Sr VP, Legal, Gener ... | Grant | A | 3.50 | 20,000 | 70,000 | 38,333 | 18.3 K to 38.3 K (+109.09 %) |
Aug 31 2004 | EYET | EYETECH PHARMACEUT ... | ALTSCHULER DOUGLAS H | Sr VP, Legal, Gener ... | Option Exercise | M | 3.50 | 20,000 | 70,000 | 141,429 | |
Aug 31 2004 | EYET | EYETECH PHARMACEUT ... | ALTSCHULER DOUGLAS H | Sr VP, Legal, Gener ... | Grant | A | 3.50 | 20,000 | 70,000 | 38,333 | 18.3 K to 38.3 K (+109.09 %) |
Aug 31 2004 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Option Exercise | M | 3.50 | 15,000 | 52,500 | 231,429 | |
Aug 31 2004 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Sell | S | 34.96 | 15,000 | 524,400 | 0 | 15 K to 0 (-100.00 %) |
Aug 31 2004 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Buy | M | 3.50 | 15,000 | 52,500 | 15,000 | 0 to 15 K |
Aug 24 2004 | EYET | EYETECH PHARMACEUT ... | ALTSCHULER DOUGLAS H | Sr VP, Legal, Gener ... | Option Exercise | M | 3.50 | 10,000 | 35,000 | 161,429 | |
Aug 24 2004 | EYET | EYETECH PHARMACEUT ... | ALTSCHULER DOUGLAS H | Sr VP, Legal, Gener ... | Grant | A | 3.50 | 10,000 | 35,000 | 18,333 | 8.3 K to 18.3 K (+120.00 %) |
Jul 20 2004 | EYET | EYETECH PHARMACEUT ... | GLICK MARTY | Director | Sell | J | 40.90 | 28,625 | 1,170,763 | 540,000 | 568.6 K to 540 K (-5.03 %) |
Aug 02 2004 | EYET | EYETECH PHARMACEUT ... | ALTSCHULER DOUGLAS H | Sr VP, Legal, Gener ... | Option Exercise | M | 3.50 | 8,333 | 29,166 | 20,238 | |
Aug 02 2004 | EYET | EYETECH PHARMACEUT ... | ALTSCHULER DOUGLAS H | Sr VP, Legal, Gener ... | Buy | M | 3.50 | 8,333 | 29,166 | 8,333 | 0 to 8.3 K |
Jun 22 2004 | EYET | EYETECH PHARMACEUT ... | Regan Michael J | Director | Option Exercise | A | 47.95 | 50,000 | 2,397,500 | 50,000 | |
Jun 22 2004 | EYET | EYETECH PHARMACEUT ... | Regan Michael J | Director | Option Exercise | A | 47.95 | 50,000 | 2,397,500 | 50,000 | |
Jun 04 2004 | EYET | EYETECH PHARMACEUT ... | PATEL SAMIR CHANDRAKANT | Director | Sell | D | 38.50 | 81,000 | 3,118,500 | 434,000 | 515 K to 434 K (-15.73 %) |
Jun 16 2004 | EYET | EYETECH PHARMACEUT ... | SATOW PHILLIP M | Director | Option Exercise | A | 41.00 | 50,000 | 2,050,000 | 50,000 | |
Jun 04 2004 | EYET | EYETECH PHARMACEUT ... | GUYER DAVID R | Chief Executive Off ... | Sell | D | 38.50 | 220,500 | 8,489,250 | 1,249,500 | 1.5 M to 1.2 M (-15.00 %) |
Jun 04 2004 | EYET | EYETECH PHARMACEUT ... | ADAMIS ANTHONY P | Chief Scientific Of ... | Sell | D | 38.50 | 43,116 | 1,659,966 | 19,324 | 62.4 K to 19.3 K (-69.05 %) |
Jun 04 2004 | EYET | EYETECH PHARMACEUT ... | JP MORGAN PARTNERS BHCA LP | 10% Owner | Sell | S | 38.50 | 810,223 | 31,193,586 | 3,240,896 | 4.1 M to 3.2 M (-20.00 %) |
Jun 04 2004 | EYET | EYETECH PHARMACEUT ... | AKKARAJU SRINIVAS | Director | Sell | S | 38.50 | 810,223 | 31,193,586 | 3,240,896 | 4.1 M to 3.2 M (-20.00 %) |
Jun 04 2004 | EYET | EYETECH PHARMACEUT ... | AKKARAJU SRINIVAS | Director | Sell | S | 38.50 | 810,223 | 31,193,586 | 3,240,896 | 4.1 M to 3.2 M (-20.00 %) |
Jun 04 2004 | EYET | EYETECH PHARMACEUT ... | WICKER DAMION E MD | Director | Sell | S | 38.50 | 810,223 | 31,193,586 | 3,240,896 | 4.1 M to 3.2 M (-20.00 %) |
May 14 2004 | EYET | EYETECH PHARMACEUT ... | GLICK MARTY | Director | Option Exercise | A | 34.34 | 10,000 | 343,400 | 10,000 | |
Jun 02 2004 | EYET | EYETECH PHARMACEUT ... | PENHOET EDWARD | Director | Sell | S | 36.50 | 10,179 | 371,534 | 27,229 | 37.4 K to 27.2 K (-27.21 %) |
Jun 02 2004 | EYET | EYETECH PHARMACEUT ... | PENHOET EDWARD | Director | Sell | S | 36.50 | 339,971 | 12,408,942 | 909,385 | 1.2 M to 909.4 K (-27.21 %) |
May 14 2004 | EYET | EYETECH PHARMACEUT ... | MCLAUGHLIN JOHN PETER | Director | Option Exercise | A | 34.34 | 10,000 | 343,400 | 10,000 | |
May 14 2004 | EYET | EYETECH PHARMACEUT ... | SIMON HENRY | Director | Option Exercise | A | 34.34 | 10,000 | 343,400 | 10,000 | |
May 14 2004 | EYET | EYETECH PHARMACEUT ... | SIMON HENRY | Director | Option Exercise | A | 34.34 | 10,000 | 343,400 | 10,000 | |
May 14 2004 | EYET | EYETECH PHARMACEUT ... | PENHOET EDWARD | Director | Option Exercise | A | 34.34 | 10,000 | 343,400 | 10,000 | |
May 14 2004 | EYET | EYETECH PHARMACEUT ... | MULLEN MICHAEL | Director | Option Exercise | A | 34.34 | 10,000 | 343,400 | 10,000 | |
May 14 2004 | EYET | EYETECH PHARMACEUT ... | JP MORGAN PARTNERS BHCA LP | 10% Owner | Option Exercise | A | 34.34 | 20,000 | 686,800 | 20,000 | |
May 14 2004 | EYET | EYETECH PHARMACEUT ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 34.34 | 10,000 | 343,400 | 10,000 | |
May 14 2004 | EYET | EYETECH PHARMACEUT ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 34.34 | 10,000 | 343,400 | 10,000 | |
May 14 2004 | EYET | EYETECH PHARMACEUT ... | WICKER DAMION E MD | Director | Option Exercise | A | 34.34 | 10,000 | 343,400 | 10,000 | |
Feb 23 2004 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | CHIEF OPERATING OFF ... | Option Exercise | A | 29.91 | 20,000 | 598,200 | 20,000 | |
Feb 23 2004 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | CFO, SR VP FINANCE | Option Exercise | A | 29.91 | 20,000 | 598,200 | 20,000 | |
Feb 23 2004 | EYET | EYETECH PHARMACEUT ... | ALTSCHULER DOUGLAS H | SR VP LEGAL, GC, SE ... | Option Exercise | A | 29.91 | 20,000 | 598,200 | 20,000 | |
Feb 23 2004 | EYET | EYETECH PHARMACEUT ... | GUYER DAVID R | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 29.91 | 20,000 | 598,200 | 20,000 | |
Feb 23 2004 | EYET | EYETECH PHARMACEUT ... | ADAMIS ANTHONY P | CSO, SR VP RESEARCH | Option Exercise | A | 29.91 | 20,000 | 598,200 | 20,000 | |
Feb 17 2004 | EYET | EYETECH PHARMACEUT ... | BIOTECH GROWTH N V | 10% Owner | Option Exercise | C | 0.00 | 1,666,665 | 0 | 0 | |
Feb 17 2004 | EYET | EYETECH PHARMACEUT ... | BIOTECH GROWTH N V | 10% Owner | Option Exercise | C | 0.00 | 1,764,697 | 0 | 0 | |
Feb 17 2004 | EYET | EYETECH PHARMACEUT ... | BIOTECH GROWTH N V | 10% Owner | Buy | C | 0.00 | 1,666,665 | 0 | 3,476,362 | 1.8 M to 3.5 M (+92.10 %) |
Feb 17 2004 | EYET | EYETECH PHARMACEUT ... | BIOTECH GROWTH N V | 10% Owner | Buy | C | 0.00 | 1,764,697 | 0 | 3,476,362 | 1.7 M to 3.5 M (+103.10 %) |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | PATEL SAMIR CHANDRAKANT | Director | Option Exercise | C | 0.00 | 40,000 | 0 | 0 | |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | PATEL SAMIR CHANDRAKANT | Director | Buy | C | 0.00 | 40,000 | 0 | 515,000 | 475 K to 515 K (+8.42 %) |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | GLICK MARTY | Director | Option Exercise | C | 0.00 | 40,000 | 0 | 0 | |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | GLICK MARTY | Director | Buy | C | 0.00 | 40,000 | 0 | 568,625 | 528.6 K to 568.6 K (+7.57 %) |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | MCLAUGHLIN JOHN PETER | Director | Option Exercise | C | 0.00 | 40,000 | 0 | 0 | |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | MCLAUGHLIN JOHN PETER | Director | Buy | C | 0.00 | 40,000 | 0 | 50,000 | 10 K to 50 K (+400.00 %) |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | MULLEN MICHAEL | Director | Option Exercise | C | 0.00 | 1,666,665 | 0 | 0 | |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | MULLEN MICHAEL | Director | Option Exercise | C | 0.00 | 1,764,697 | 0 | 1,666,665 | |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | MULLEN MICHAEL | Director | Buy | C | 0.00 | 1,666,665 | 0 | 3,431,362 | 1.8 M to 3.4 M (+94.44 %) |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | MULLEN MICHAEL | Director | Buy | C | 0.00 | 1,764,697 | 0 | 1,764,697 | 0 to 1.8 M |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | PENHOET EDWARD | Director | Option Exercise | C | 0.00 | 101,138 | 0 | 0 | |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | PENHOET EDWARD | Director | Option Exercise | X | 0.00 | 101,138 | 0 | 101,138 | |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | PENHOET EDWARD | Director | Option Exercise | X | 7.20 | 101,138 | 728,194 | 101,138 | |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | PENHOET EDWARD | Director | Option Exercise | C | 0.00 | 107,088 | 0 | 101,138 | |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | PENHOET EDWARD | Director | Option Exercise | X | 0.00 | 107,088 | 0 | 208,226 | |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | PENHOET EDWARD | Director | Option Exercise | X | 6.80 | 107,088 | 728,198 | 208,226 | |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | PENHOET EDWARD | Director | Option Exercise | C | 0.00 | 505,692 | 0 | 208,226 | |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | PENHOET EDWARD | Director | Option Exercise | C | 0.00 | 535,438 | 0 | 713,918 | |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | PENHOET EDWARD | Director | Buy | C | 0.00 | 101,138 | 0 | 1,249,356 | 1.1 M to 1.2 M (+8.81 %) |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | PENHOET EDWARD | Director | Buy | C | 0.00 | 107,088 | 0 | 1,148,218 | 1 M to 1.1 M (+10.29 %) |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | PENHOET EDWARD | Director | Buy | C | 0.00 | 505,692 | 0 | 1,041,130 | 535.4 K to 1 M (+94.44 %) |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | PENHOET EDWARD | Director | Buy | C | 0.00 | 535,438 | 0 | 535,438 | 0 to 535.4 K |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | WICKER DAMION E MD | Director | Option Exercise | X | 7.20 | 347,222 | 2,499,998 | 0 | |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | WICKER DAMION E MD | Director | Option Exercise | X | 6.80 | 367,647 | 2,500,000 | 0 | |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | WICKER DAMION E MD | Director | Option Exercise | C | 0.00 | 1,736,111 | 0 | 0 | |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | WICKER DAMION E MD | Director | Option Exercise | C | 0.00 | 1,838,235 | 0 | 0 | |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | WICKER DAMION E MD | Director | Grant | A | 7.20 | 347,222 | 2,499,998 | 4,289,215 | 3.9 M to 4.3 M (+8.81 %) |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | WICKER DAMION E MD | Director | Grant | A | 6.80 | 367,647 | 2,500,000 | 4,289,215 | 3.9 M to 4.3 M (+9.38 %) |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | WICKER DAMION E MD | Director | Buy | C | 0.00 | 1,736,111 | 0 | 4,289,215 | 2.6 M to 4.3 M (+68.00 %) |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | WICKER DAMION E MD | Director | Buy | C | 0.00 | 1,838,235 | 0 | 4,289,215 | 2.5 M to 4.3 M (+75.00 %) |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | JP MORGAN PARTNERS BHCA LP | 10% Owner | Option Exercise | X | 7.20 | 347,222 | 2,499,998 | 0 | |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | JP MORGAN PARTNERS BHCA LP | 10% Owner | Option Exercise | X | 6.80 | 367,647 | 2,500,000 | 0 | |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | JP MORGAN PARTNERS BHCA LP | 10% Owner | Option Exercise | C | 0.00 | 1,736,111 | 0 | 0 | |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | JP MORGAN PARTNERS BHCA LP | 10% Owner | Option Exercise | C | 0.00 | 1,838,235 | 0 | 0 | |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | JP MORGAN PARTNERS BHCA LP | 10% Owner | Grant | A | 7.20 | 347,222 | 2,499,998 | 4,289,215 | 3.9 M to 4.3 M (+8.81 %) |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | JP MORGAN PARTNERS BHCA LP | 10% Owner | Grant | A | 6.80 | 367,647 | 2,500,000 | 4,289,215 | 3.9 M to 4.3 M (+9.38 %) |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | JP MORGAN PARTNERS BHCA LP | 10% Owner | Buy | C | 0.00 | 1,736,111 | 0 | 4,289,215 | 2.6 M to 4.3 M (+68.00 %) |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | JP MORGAN PARTNERS BHCA LP | 10% Owner | Buy | C | 0.00 | 1,838,235 | 0 | 4,289,215 | 2.5 M to 4.3 M (+75.00 %) |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | AKKARAJU SRINIVAS | Director | Option Exercise | X | 7.20 | 347,222 | 2,499,998 | 0 | |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | AKKARAJU SRINIVAS | Director | Option Exercise | X | 6.80 | 367,647 | 2,500,000 | 0 | |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | AKKARAJU SRINIVAS | Director | Option Exercise | C | 0.00 | 1,736,111 | 0 | 0 | |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | AKKARAJU SRINIVAS | Director | Option Exercise | C | 0.00 | 1,838,235 | 0 | 0 | |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | AKKARAJU SRINIVAS | Director | Grant | A | 7.20 | 347,222 | 2,499,998 | 4,289,215 | 3.9 M to 4.3 M (+8.81 %) |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | AKKARAJU SRINIVAS | Director | Grant | A | 6.80 | 367,647 | 2,500,000 | 4,289,215 | 3.9 M to 4.3 M (+9.38 %) |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | AKKARAJU SRINIVAS | Director | Buy | C | 0.00 | 1,736,111 | 0 | 4,289,215 | 2.6 M to 4.3 M (+68.00 %) |
Feb 06 2004 | EYET | EYETECH PHARMACEUT ... | AKKARAJU SRINIVAS | Director | Buy | C | 0.00 | 1,838,235 | 0 | 4,289,215 | 2.5 M to 4.3 M (+75.00 %) |